Chief Scientific Officer John Renger sold $350K of Cerevel Therapeutics Holdings, Inc.

Sold$350,000

$35.00Price

10,000Shares

−83%Stake

What CERE did after the filing

Prices for CERE after this filing aren't in yet.

Traded Tue, Mar 29. Filed Thu, Mar 31, 12:05 PM ET, during the session. Not investment advice.